Theravance Biopharma (TBPH) – Analyst Ratings
-
Theravance (TBPH) in Better Position Post Trelegy Deal, ampreloxetine Program Remains Key - Needham & Company Maintains Hold
-
UPDATE: SVB Leerink Assumes Theravance Biopharma (TBPH) at Outperform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TBPH Stock Lookup